Human leukocyte antigen-G 3' untranslated region polymorphisms are associated with better kidney allograft acceptance

Human Immunology

Volumn 73, Issue 1, 2012, Pages 52-59

  Cilião Alves, Daiani Cristina ^a   De Oliveira Crispim, Janaina Cristiana ^b   Castelli, Erick C ^c   Mendes Junior, Celso Teixeira ^a   Deghaide, Neifi Hassan Saloun ^a   Barros Silva, Gyl Eanes ^a   Costa, Roberto Silva ^a   Saber, Luciana Tanajura ^a   Moreau, Philippe ^d   Donadi, Eduardo Antonio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Department of Clinical and Toxicology Analysis   (Brazil)

^c FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^d Inst Univ d'Hématologie   (France)

Author keywords

3' Untranslated region; HLA G; Kidney allograft; Polymorphism; Rejection

Indexed keywords

ALANINE; AZATHIOPRINE; BASILIXIMAB; CYCLOSPORIN; CYSTEINE; GLYCINE; HLA G ANTIGEN; MEPREDNISONE; MESSENGER RNA; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; RAPAMYCIN; TACROLIMUS; THREONINE;

3' UNTRANSLATED REGION; ADULT; ARTICLE; BASE PAIRING; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INDEL MUTATION; KIDNEY ALLOGRAFT; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; POSTTRANSCRIPTIONAL GENE SILENCING; PRIORITY JOURNAL; PROTEIN DEGRADATION;

3' UNTRANSLATED REGIONS; ADOLESCENT; ADULT; AGED; ALLELES; CHILD; FEMALE; GENE FREQUENCY; GENOTYPE; GRAFT REJECTION; GRAFT SURVIVAL; HAPLOTYPES; HLA-G ANTIGENS; HUMANS; KIDNEY TRANSPLANTATION; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84355161570     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.10.007     Document Type: Article

References (40)

1. Calne R.Y. Transplantation: current developments and future directions. Rev Neurosci 2009, 20:267-273.
2. Kirk A.D. Clinical tolerance 2008. Transplantation 2009, 87:953-955.
3. Riteau B., Rouas-Freiss N., Menier C., Paul P., Dausset J., Carosella E.D. HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis. J Immunol 2001, 166:5018-5026.
4. Carosella E.D., Favier B., Rouas-Freiss N., Moreau P., LeMaoult J. Beyond the increasing complexity of the immunomodulatory HLA-G molecule. Blood 2008, 111:4862-4870.
5. Gao G.F., Willcox B.E., Wyer J.R., Boulter J.M., O'Callaghan C.A., Maenaka K., et al. Classical and nonclassical class I major histocompatibility complex molecules exhibit subtle conformational differences that affect binding to CD8alphaalpha. J Biol Chem 2000, 275:15232-15238.
6. Shiroishi M., Kuroki K., Tsumoto K., Yokota A., Sasaki T., Amano K., et al. Entropically driven MHC class I recognition by human inhibitory receptor leukocyte Ig-like receptor, B1 (LILRB1/ILT2/CD85j). J Mol Biol 2006, 355:237-248.
7. Shiroishi M., Kuroki K., Rasubala L., Tsumoto K., Kumagai I., Kurimoto E., et al. Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d). Proc Natl Acad Sci U S A 2006, 103:16412-16417.
8. Lila N., Carpentier A., Amrein C., Khalil-Daher I., Dausset J., Carosella E.D. Implication of HLA-G molecule in heart-graft acceptance. Lancet 2000, 355:2138.
9. Lila N., Amrein C., Guillemain R., Chevalier P., Latremouille C., Fabiani J.N., et al. Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection. Circulation 2002, 105:1949-1954.
10. Lila N., Amrein C., Guillemain R., Chevalier P., Fabiani J.N., Carpentier A. Soluble human leukocyte antigen-G: A new strategy for monitoring acute and chronic rejections after heart transplantation. J Heart Lung Transplant 2007, 26:421-422.
11. Luque J., Torres M.I., Aumente M.D., Lozano J.M., Garcia-Jurado G., Gonzalez R., et al. sHLA-G levels in the monitoring of immunosuppressive therapy and rejection following heart transplantation. Transpl Immunol 2006, 17:70-73.
12. Creput C., Le F.G., Bahri R., Amiot L., Charpentier B., Carosella E., et al. Detection of HLA-G in serum and graft biopsy associated with fewer acute rejections following combined liver-kidney transplantation: Possible implications for monitoring patients. Hum Immunol 2003, 64:1033-1038.
13. Créput C., Durrbach A., Menier C., Guettier C., Samuel D., Dausset J., et al. Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation. J Hepatol 2003, 39:587-594.
14. Crispim J.C., Duarte R.A., Soares C.P., Costa R., Silva J.S., Mendes-Júnior C.T., et al. Human leukocyte antigen-G expression after kidney transplantation is associated with a reduced incidence of rejection. Transpl Immunol 2008, 18:361-367.
15. Brugière O., Thabut G., Pretolani M., Krawice-Radanne I., Dill C., Herbreteau A., et al. Immunohistochemical study of HLA-G expression in lung transplant recipients. Am J Transplant 2009, 9:1427-1438.
16. +CD8low are induced by HLA-G: Novel human peripheral blood suppressor T-cell subsets involved in transplant acceptance. Blood 2007, 110:3936-3948.
17. Crispim J.C., Mendes-Junior C.T., Wastowski I.J., Costa R., Castelli E.C., Saber L.T., et al. Frequency of insertion/deletion polymorphism in exon 8 of HLA-G and kidney allograft outcome. Tissue Antigens 2008, 71:35-41.
18. Piancatelli D., Maccarone D., Liberatore G., Parzanese I., Clemente K., Azzarone R., et al. HLA-G 14-bp insertion/deletion polymorphism in kidney transplant patients with metabolic complications. Transplant Proc 2009, 41:1187-1188.
19. Rebmann V., Bartsch D., Wunsch A., Möllenbeck P., Golda T., Viebahn R., et al. Soluble total human leukocyte antigen class I and human leukocyte antigen-G molecules in kidney and kidney/pancreas transplantation. Hum Immunol 2009, 70:995-999.
20. Torres M.I., Luque J., Lorite P., Isla-Tejera B., Palomeque T., Aumente M.D., et al. 14-Base pair polymorphism of human leukocyte antigen-G as genetic determinant in heart transplantation and cyclosporine therapy monitoring. Hum Immunol 2009, 70:830-835.
21. Hviid T.V., Rizzo R., Melchiorri L., Stignani M., Baricordi O.R. Polymorphism in the 5' upstream regulatory and 3' untranslated regions of the HLA-G gene in relation to soluble HLA-G and IL-10 expression. Hum Immunol 2006, 67:53-62.
22. Castelli E.C., Mendes-Junior C.T., Deghaide N.H., de Albuquerque R.S., Muniz Y.C., Simões R.T., et al. The genetic structure of 3untranslated region of the HLA-G gene: Polymorphisms and haplotypes. Genes Immun 2010, 11:134-141.
23. Hiby S.E., King A., Sharkey A., Loke Y.W. Molecular studies of trophoblast HLA-G: Polymorphism, isoforms, imprinting and expression in preimplantation embryo. Tissue Antigens 1999, 53:1-13.
24. Hviid T.V., Hylenius S., Rørbye C., Nielsen L.G. HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 2003, 55:63-79.
25. O'Brien M., McCarthy T., Jenkins D., Paul P., Dausset J., Carosella E.D., et al. Altered HLA-G transcription in pre-eclampsia is associated with allele specific inheritance: Possible role of the HLA-G gene in susceptibility to the disease. Cell Mol Life Sci 2001, 58:1943-1949.
26. Rousseau P., Le D.M., Mouillot G., Marcou C., Carosella E.D., Moreau P. The 14 bp deletion-insertion polymorphism in the 3' UT region of the HLA-G gene influences HLA-G mRNA stability. Hum Immunol 2003, 64:1005-1010.
27. Tan Z., Randall G., Fan J., Camoretti-Mercado B., Brockman-Schneider R., Pan L., et al. Allele-specific targeting of microRNAs to HLA-G and risk of asthma. Am J Hum Genet 2007, 81:829-834.
28. Veit T.D., Chies J.A. Tolerance versus immune response-microRNAs as important elements in the regulation of the HLA-G gene expression. Transpl Immunol 2009, 20:229-231.
29. Yie S.M., Li L.H., Xiao R., Librach C.L. A single base-pair mutation in the 3-untranslated region of HLA-G mRNA is associated with pre-eclampsia. Mol Hum Reprod 2008, 14:649-653.
30. Castelli E.C., Moreau P., e Chiromatzo O., Mendes-Junior C.T., Veiga-Castelli L.C., Yaghi L., et al. In silico analysis of microRNAs targeting the HLA-G 3' untranslated region alleles and haplotypes. Hum Immunol 2009, 70:1020-1025.
31. Solez K., Colvin R.B., Racusen L.C., Sis B., Halloran P.F., Birk P.E., et al. Banff 2005 Meeting Report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ("CAN"). Am J Transplant 2007, 7:518-526.
32. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16:1215.
33. Guo S.W., Thompson E.A. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 1992, 48:361-372.
34. Raymond M., Rousset F. Population genetics software for exact tests and ecumenicism. J Hered 1995, 86:248-249. GENEPOP (version 1.2).
35. Excoffier L., Slatkin M. Incorporating genotypes of relatives into a test of linkage disequilibrium. Am J Hum Genet 1998, 62:171-180.
36. Excoffier L., Laval G., Schneider S. Arlequin (version 3.0): An integrated software package for population genetics data analysis. Evol Bioinform Online 2005, 1:47-50.
37. Stephens M., Smith N.J., Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001, 68:978-989.
38. Donadi E.A., Castelli E.C., Rnaiz-Villena A., Roger M., Rey D., Moreau P. Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association. Cell Mol Life Sci 2011, 68:369-395.
39. Luque J., Torres M.I., Aumente M.D., Marin J., Garcia-Jurado G., Gonzalez R., et al. Soluble HLA-G in heart transplantation: Their relationship to rejection episodes and immunosuppressive therapy. Hum Immunol 2006, 67:257-263.
40. Castelli E.C., Mendes-Junior C.T., Veiga-Castelli L.C., Roger M., Moreau P., Donadi E.A. A comprehensive study of polymorphic sites along the HLA-G gene: Implication for gene regulation and evolution. Mol Biol Evol 2011, 28:3069-3086.